Evaluation of health-related quality of life using EQ-5D in China during the COVID-19 pandemic

Weiwei Ping, Jianzhong Zheng, Xiaohong Niu, Chongzheng Guo, Jinfang Zhang, Hui Yang, Yan Shi, Weiwei Ping, Jianzhong Zheng, Xiaohong Niu, Chongzheng Guo, Jinfang Zhang, Hui Yang, Yan Shi

Abstract

Objective: Since December 2019, an increasing number of cases of the 2019 novel coronavirus disease (COVID-19) infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been identified in Wuhan, Hubei Province, China. Now, more cases have been reported in 200 other countries and regions. The pandemic disease not only affects physical health who suffered it, but also affects the mental health of the general population. This study aims to know about the impact of the COVID-19 epidemic on the health-related quality of life (HRQOL) of living using EQ-5D in general population in China.

Methods: An online-based survey was developed and participants were recruited via social media. The questionnaires included demographic and socioeconomic data, health status, the condition epidemic situation and EQ-5D scale. The relationships of all factors and the scores of EQ-5D were analyzed. Logistic regression model were used to the five health dimensions.

Results: The respondents obtained a mean EQ-5D index score of 0.949 and a mean VAS score of 85.52.The most frequently reported problem were pain/discomfort (19.0%) and anxiety/depression (17.6%). Logistic regression models showed that the risk of pain/discomfort and anxiety/depression among people with aging, with chronic disease, lower income, epidemic effects, worry about get COVID-19 raised significantly.

Conclusion: The article provides important evidence on HRQOL during the COVID-19 pandemic. The risk of pain/discomfort and anxiety/depression in general population in China raised significantly with aging, with chronic disease, lower income, epidemic effects, worried about get COVID-19 during the COVID-19 pandemic. The results from each categorical data can be used for future healthcare measures among general population.

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727–33. 10.1056/NEJMoa2001017
    1. National Health Commission of the People`s Republic of China. Coronavirus Disease (COVID-19) Pandemic. Available from: .
    1. World Health Organization. Coronavirus Disease (COVID-19) Pandemic. Available from:.
    1. Chinese Center for Disease Control and Prevention. Health Topic. Infections Disease. Coronavirus Disease (COVID-19) Pandemic. Available from:
    1. Su M, Zhou Z, Si Y, Wei X, Xu Y, Fan X, et al. Comparing the effects of China’s three basic health insurance schemes on the equity of health-related quality of life: Using the method of coarsened exact matching. Health and Quality of Life Outcomes, 2018; 16(1), 41 10.1186/s12955-018-0868-0
    1. Xie Y, Yu Y, Wang JX, Yang X, Zhao F, Ma JQ, et al. Health-related quality of life and its influencing factors in Chinese with knee osteoarthritis. Qual Life Res. 2020;20 10.1007/s11136-020-02502-9
    1. Tan X, Zhang Y, Shao H. Healthy China 2030, a breakthrough for improving health. Glob Health Promot. 2019; 26(4):96–99. 10.1177/1757975917743533
    1. Skevington SM, Lotfy M, O'Connell KA, WHOQOL Group. Qual Life Res. The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group.2004; 13(2):299–310. 10.1023/B:QURE.0000018486.91360.00
    1. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med. 1993;118(8):622‐629. 10.7326/0003-4819-118-8-199304150-00009
    1. Sprangers MA, Cull A, Bjordal K, Groenvold M, Aaronson NK. The European Organization for Research and Treatment of Cancer. Approach to quality of life assessment: guidelines for developing questionnaire modules. EORTC Study Group on Quality of Life.Qual Life Res 1993;2:287–295. 10.1007/BF00434800
    1. Jenkinson C, Coulter A, Wright L. Short form 36 (SF36) health survey questionnaire: normative data for adults of working age. BMJ. 1993;306(6890):1437‐1440. 10.1136/bmj.306.6890.1437
    1. Feeny D, Furlong W, Boyle M, Torrance GW. Multi-attribute health status classification systems. Health Utilities Index. Pharmacoeconomics. 1995;7(6):490‐502. 10.2165/00019053-199507060-00004
    1. Liu GG, Wu H, Li M, Gao C, Luo N. Chinese Time Trade-Off Values for EQ-5D Health States.Value Health 2014, 17, 597–604. 10.1016/j.jval.2014.05.007
    1. Burstrom K, Johannesson M, Diderichsen F. Swedish population health-related quality of life results using the EQ-5D. Qual Life Res. 2001; 10:621–35. 10.1023/a:1013171831202
    1. Johnson JA, Coons SJ. Comparison of the EQ-5D and SF-12 in an adult US sample. Qual Life Res. 1998; 7(2):155–66. 10.1023/a:1008809610703
    1. Johnson AJ, Pickard AS. Comparison of the EQ-5D and SF-12 health surveys in a general population survey in Alberta, Canada. Med Care. 2000; 38:115–21. 10.1097/00005650-200001000-00013
    1. Jelsma J, Ferguson G. The determinants of self-reported health-related quality of life in a culturally and socially diverse South African community. Bull World Health Organ. 2004; 82:206–12.
    1. Chang TJ, Tarn YH, Hsieh CL, Liou WS, Shaw JW, Chiou XG. Taiwanese version of the EQ-5D: Validation in a representative sample of the Taiwanese population. J. Formos. Med. Assoc. 2007, 106, 1023–1031. 10.1016/S0929-6646(08)60078-9
    1. Wang H, Kindig DA, Mullahy J. Variation in Chinese population health related quality of life: results from a EuroQol study in Beijing,China.Qual Life Res. 2005;14(1):119‐132. 10.1007/s11136-004-0612-6
    1. Sun S, Chen J, Johannesson M, Kind P, Xu L, Zhang Y, et al. Population health status in China: EQ-5D results, by age, sex and socio-economic status, from the National Health Services Survey 2008.Qual. Life Res. 2010, 20, 309–320. 10.1007/s11136-010-9762-x
    1. Abdin E, Subramaniam M, Vaingankar JA, Luo N, Chong SA. Measuring health-related quality of life among adults in Singapore: population norms for the EQ-5D.Qual Life Res 2013;22:2983–2991. 10.1007/s11136-013-0405-x
    1. Luo N, Johnson JA, Shaw JW, Feeny D, Coons SJ. Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index. Med Care. 2005;43(11):1078‐1086. 10.1097/01.mlr.0000182493.57090.c1
    1. Sørensen J, Davidsen M, Gudex C, Pedersen KM, Brønnum-Hansen H. Danish EQ-5D population norms. Scand J Public Health. 2009;37(5):467‐474. 10.1177/1403494809105286
    1. Bammann K, Kularatna S, Whitty JA, Johnson NW, Jayasinghe R, Scuffham PA. EQ-5D-3L Derived Population Norms for Health Related Quality of Life in Sri Lanka. PLoS ONE 2014; 9, e108434 10.1371/journal.pone.0108434
    1. Fujikawa A, Suzue T, Jitsunari F, Hirao T. Evaluation of health-related quality of life using EQ-5D in Takamatsu, Japan.Environ Health Prev Med. 2011; 16(1):25–35. 10.1007/s12199-010-0162-1
    1. Huang W, Yu H, Liu C, Liu G, Wu Q, Zhou J, et al. Assessing Health-Related Quality of Life of Chinese Adults in Heilongjiang Using EQ-5D-3L. Int J Environ Res Public Health. 2017; 14(3): 224 10.3390/ijerph14030224
    1. Yu ST, Chang HY, Yao KP, Lin YH, Hurng BS. Validity of EQ-5D in general population of Taiwan: results of the 2009 National Health Interview and Drug Abuse Survey of Taiwan. Qual Life Res. 2015;24(10):2541‐2548. 10.1007/s11136-015-0978-7
    1. National Bureau of Statistic of China. National data. Available from: .
    1. Wong ELY, Xu RH, Cheung AWL. Health-related quality of life among patients with hypertension: population-based survey using EQ-5D-5L in Hong Kong SAR, China. BMJ Open. 2019;9(9):e032544 10.1136/bmjopen-2019-032544
    1. Zhuang Y, Ma QH, Pan CW. Health-related quality of life in older Chinese patients with diabetes. PLoS One 2020;15:e0229652 10.1371/journal.pone.0229652
    1. Kind P, Dolan P, Gudex C, Williams A. Variations in population health status: Results from a United Kingdom national questionnaire survey. British Medical Journal, 1998; 316(7133), 736–741. 10.1136/bmj.316.7133.736
    1. Golicki D, Niewada M, Jakubczyk M, Wrona W, Hermanowski T. Self-assessed health status in Poland: EQ-5D findings from the Polish valuation study. Pol Arch Med Wewn. 2010;120(7–8):276‐281.
    1. Kontodimopoulos N, Pappa E, Niakas D, Yfantopoulos J, Dimitrakaki C, Tountas Y. Validity of the EuroQoL (EQ-5D) instrument in a Greek general population. Value Health. 2008;11(7):1162‐1169. 10.1111/j.1524-4733.2008.00356.x
    1. Liu X, Kakade M, Fuller CJ, Fan B, Fang Y, Kong J, et al. Depression after exposure to stressful events: lessons learned from the severe acute respiratory syndrome epidemic. Compr Psychiatry. 2012; 53(1):15–23. 10.1016/j.comppsych.2011.02.003
    1. Jeong H, Yim HW, Song YJ, Ki M, Min J, Cho J, et al. Mental health status of people isolated due to Middle East Respiratory Syndrome. Epidemiol Health. 2016;38:e2016048 10.4178/epih.e2016048
    1. Kang L, Ma S, Chen M, Yang J, Wang Y, Li R, et al. Impact on mental health and perceptions of psychological care among medical and nursing staff in Wuhan during the 2019 novel coronavirus disease outbreak: A cross-sectional study. Brain Behav Immun. 2020;. 10.1016/j.bbi.2020.03.028
    1. Teris Cheung, Tommy K.H. Fong and Daniel Bressington.COVID-19 under the SARS Cloud: Mental Health Nursing during the Pandemic in Hong Kong. 10.1111/JPM.12639
    1. Ahorsu DK, Lin CY, Imani V, Saffari M, Griffiths MD, Pakpour AH. The Fear of COVID-19 Scale: Development and Initial Validation. Int J Ment Health Addict. 2020;1‐9. 10.1007/s11469-020-00270-8
    1. Taylor S, Landry CA, Paluszek MM, Fergus TA, McKay D, Asmundson GJG. Development and initial validation of the COVID Stress Scales. J Anxiety Disord. 2020;72:102232 10.1016/j.janxdis.2020.102232

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere